Application

ERWINAZE

Porton Biopharma Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90081574
Filing Date: 07/29/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90081574
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\900\815\90081574\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT ERWINAZE
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word ERWINAZE to the left of a multi-lined design.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 701 x 197
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Porton Biopharma Limited
INTERNAL ADDRESS Manor Farm Road
*MAILING ADDRESS Porton, Salisbury
*CITY Wiltshire
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United Kingdom
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
SP40JG
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE private limited company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED United Kingdom
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations, namely injectable pharmaceutical compositions comprising compounds having asparaginase activity
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 4147569.
ATTORNEY INFORMATION
NAME Rebecca Liebowitz
ATTORNEY DOCKET NUMBER 31916-526234
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME VENABLE LLP
STREET P.O. Box 34385
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20043
PHONE 202-344-4000
FAX 202 344 8300
EMAIL ADDRESS trademarkdocket@venable.com
OTHER APPOINTED ATTORNEY Andrew Price, Halle Markus, Kristen Ruisi, Steven Powell, Marjorie Norman, Catherine Mitros, Paula Hopkins, Sean Phelan, Tanya Curcio, Renato Perez
DOMESTIC REPRESENTATIVE INFORMATION
NAME Rebecca Liebowitz
FIRM NAME VENABLE LLP
STREET P.O. Box 34385
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 20043
PHONE 202-344-4000
FAX 202 344 8300
EMAIL ADDRESS trademarkdocket@venable.com
CORRESPONDENCE INFORMATION
NAME Rebecca Liebowitz
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarkdocket@venable.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) rliebowitz@venable.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90081574
Filing Date: 07/29/2020

To the Commissioner for Trademarks:

MARK: ERWINAZE (stylized and/or with design, see mark)
The literal element of the mark consists of ERWINAZE. The mark consists of the word ERWINAZE to the left of a multi-lined design.
The applicant, Porton Biopharma Limited, a private limited company legally organized under the laws of United Kingdom, having an address of
      Manor Farm Road
      Porton, Salisbury
      Wiltshire SP40JG
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations, namely injectable pharmaceutical compositions comprising compounds having asparaginase activity
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 4147569.


The owner's/holder's proposed attorney information: Rebecca Liebowitz. Other appointed attorneys are Andrew Price, Halle Markus, Kristen Ruisi, Steven Powell, Marjorie Norman, Catherine Mitros, Paula Hopkins, Sean Phelan, Tanya Curcio, Renato Perez. Rebecca Liebowitz of VENABLE LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      P.O. Box 34385
      Washington, District of Columbia 20043
      United States
      202-344-4000(phone)
      202 344 8300(fax)
      trademarkdocket@venable.com
The docket/reference number is 31916-526234.
Rebecca Liebowitz submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Rebecca Liebowitz of VENABLE LLP
      P.O. Box 34385
      Washington District of Columbia 20043
      United States
      202-344-4000(phone)
      202 344 8300(fax)
      trademarkdocket@venable.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.


The applicant's current Correspondence Information:
      Rebecca Liebowitz
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarkdocket@venable.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rliebowitz@venable.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 90081574
Payment Accounting Date: 07/29/2020

Serial Number: 90081574
Internet Transmission Date: Wed Jul 29 18:53:45 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.XXX-202007291853458
78770-90081574-740657e41946a30dfde5aad67
489582d8b0b6cb73b47f2f168ef4d21817a3d8a9
-CC-53440804-20200729184736860002

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed